Cumberland Pharmaceuticals Inc (NAS:CPIX)
$ 1.28 0.03 (2.4%) Market Cap: 18.04 Mil Enterprise Value: 21.85 Mil PE Ratio: 0 PB Ratio: 0.68 GF Score: 51/100

Q1 2022 Cumberland Pharmaceuticals Inc Earnings Call Transcript

May 10, 2022 / 08:30PM GMT
Release Date Price: $2.58 (-1.53%)
Operator

Good afternoon, and thank you for joining Cumberland Pharmaceuticals First Quarter 2022 Financial Report and Company Update. This call is being recorded at the company's request and will be archived on Cumberland's website for 1 week from today's date. I would now like to introduce, Molly Aggas, Account Supervisor at the Dalton Agency, who handles Cumberland's communications. Molly, please go ahead.

Molly Aggas

Hi, everyone, and good afternoon. Earlier today, Cumberland issued a press release containing a company update and financial results for the first quarter of 2022. The release, which includes related financial tables can be found on Cumberland's website at www.cumberlandpharma.com. Company management will share an overview of these results during today's call. With us today are A.J. Kazimi, Cumberland's Chief Executive Officer; Todd Anthony, Vice President; and John Hamm, Chief Financial Officer. Please keep in mind that today's discussion may include forward-looking statements as defined

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot